450 related articles for article (PubMed ID: 19379066)
41. The Transition From Hypertension to Heart Failure: Contemporary Update.
Messerli FH; Rimoldi SF; Bangalore S
JACC Heart Fail; 2017 Aug; 5(8):543-551. PubMed ID: 28711447
[TBL] [Abstract][Full Text] [Related]
42. [Diagnosis and therapy for diastolic heart failure].
Anguita Sánchez M; Ojeda Pineda S
Rev Esp Cardiol; 2004 Jun; 57(6):570-5. PubMed ID: 15225503
[TBL] [Abstract][Full Text] [Related]
43. [Heart failure in chronic kidney disease: from epidemiology to therapy].
Zamboli P; De Nicola L; Minutolo R; Stanzione G; Bertino V; Sosio R; De Luca A; Crivaro M; Tassinario S; Conte G
G Ital Nefrol; 2007; 24(6):574-83. PubMed ID: 18278761
[TBL] [Abstract][Full Text] [Related]
44. Heart failure in patients with chronic kidney disease.
Lisowska A; Musiał WJ
Rocz Akad Med Bialymst; 2004; 49():162-5. PubMed ID: 15631334
[TBL] [Abstract][Full Text] [Related]
45. Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF).
Forman DE; Cannon CP; Hernandez AF; Liang L; Yancy C; Fonarow GC;
Am Heart J; 2009 Jun; 157(6):1010-7. PubMed ID: 19464411
[TBL] [Abstract][Full Text] [Related]
46. Chronic heart failure, selected risk factors and co-morbidities among adults treated for hypertension in a cardiac referral hospital in Cameroon.
Dzudie A; Kengne AP; Mbahe S; Menanga A; Kenfack M; Kingue S
Eur J Heart Fail; 2008 Apr; 10(4):367-72. PubMed ID: 18353716
[TBL] [Abstract][Full Text] [Related]
47. A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure.
Koracevic G; Perisic Z; Stanojkovic M; Stojanovic M; Zdravkovic M; Tomasevic M; Djordjevic D; Mladenovic K; Koracevic M; Trkulja J
Med Princ Pract; 2022; 31(5):454-462. PubMed ID: 36044874
[TBL] [Abstract][Full Text] [Related]
48. From hypertension to heart failure -- are there better primary prevention strategies?
Meredith PA; Ostergren J
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):64-73. PubMed ID: 17083060
[TBL] [Abstract][Full Text] [Related]
49. [Hypertension and the heart].
Wachtell K; Andersen NH; Svendsen TL
Ugeskr Laeger; 2009 Jun; 171(25):2113-6. PubMed ID: 19671394
[TBL] [Abstract][Full Text] [Related]
50. Treatment of hypertension in heart failure with preserved ejection fraction: role of the kidney.
Shinde AA; Anderson AS
Heart Fail Clin; 2008 Oct; 4(4):479-503. PubMed ID: 18760759
[TBL] [Abstract][Full Text] [Related]
51. Assessment of drug therapy management and the prevalence of heart failure in a managed care population with hypertension.
Jackson JH; Frech F; Ronen R; Mullany L; Lennert B; Jhaveri V
J Manag Care Pharm; 2004; 10(6):513-20. PubMed ID: 15548123
[TBL] [Abstract][Full Text] [Related]
52. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group.
Schocken DD; Benjamin EJ; Fonarow GC; Krumholz HM; Levy D; Mensah GA; Narula J; Shor ES; Young JB; Hong Y; ; ; ; ; ;
Circulation; 2008 May; 117(19):2544-65. PubMed ID: 18391114
[TBL] [Abstract][Full Text] [Related]
53. Acute heart failure with preserved systolic function.
Kumar R; Gandhi SK; Little WC
Crit Care Med; 2008 Jan; 36(1 Suppl):S52-6. PubMed ID: 18158478
[TBL] [Abstract][Full Text] [Related]
54. A novel pathway for the management of hypertension for hospitalized patients.
Herzog E; Frankenberger O; Aziz E; Bangalore S; Balaram S; Nasrallah EJ; Cortell S; Messerli FH
Crit Pathw Cardiol; 2007 Dec; 6(4):150-60. PubMed ID: 18091404
[TBL] [Abstract][Full Text] [Related]
55. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
56. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
Norgard NB; Stark JE
Pharmacotherapy; 2008 Jul; 28(7):920-31. PubMed ID: 18576907
[TBL] [Abstract][Full Text] [Related]
57. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.
Fortuna P; Reis I; Ascenção R; Carneiro AV
Rev Port Cardiol; 2008; 27(7-8):977-89. PubMed ID: 18959094
[TBL] [Abstract][Full Text] [Related]
58. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
[TBL] [Abstract][Full Text] [Related]
59. Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction.
Tehrani F; Phan A; Chien CV; Morrissey RP; Rafique AM; Schwarz ER
Am J Cardiol; 2009 Mar; 103(6):829-33. PubMed ID: 19268740
[TBL] [Abstract][Full Text] [Related]
60. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
